Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.
Use of T-VEC in early metastatic melanoma
Ms Viola Franke - Netherlands Cancer Institute, Amsterdam, Netherlands
Use of T-VEC in early metastatic melanoma ( Ms Viola Franke - Netherlands Cancer Institute, Amsterdam, Netherlands )
21 Oct 2018
Expansion from CHECKMATE-032; nivolumab and ipilimumab for metastatic urothelial...
Dr Jonathan E. Rosenberg - Memorial Sloan-Kettering Cancer Institute, New York, ...
Expansion from CHECKMATE-032; nivolumab and ipilimumab for metastatic urothelial carcinoma ( Dr Jonathan E. Rosenberg - Memorial Sloan-Kettering Cancer Institute, New York, USA )
21 Oct 2018
Editor's Choice for June 2018
Prof Gordon McVie - Founding Editor, ecancer
Editor's Choice for June 2018 ( Prof Gordon McVie - Founding Editor, ecancer )
4 Jul 2018
EHA 2018: The unmet needs in maintenance therapy for multiple myeloma
Prof Meletios Dimopoulos, Dr Shaji Kumar, Prof Meral Beksaç and Prof Wee Joo Ch...
EHA 2018: The unmet needs in maintenance therapy for multiple myeloma ( Prof Meletios Dimopoulos, Dr Shaji Kumar, Prof Meral Beksaç and Prof Wee Joo Chng )
15 Jun 2018
Updates in melanoma from ASCO 2018
Dr Alexander van Akkooi - Netherlands Cancer Institute, Amsterdam, Netherlands
Updates in melanoma from ASCO 2018 ( Dr Alexander van Akkooi - Netherlands Cancer Institute, Amsterdam, Netherlands )
4 Jun 2018
Editor’s Choice for May 2018
Prof Gordon McVie - Founding Editor, ecancer
Editor’s Choice for May 2018 ( Prof Gordon McVie - Founding Editor, ecancer )
21 May 2018
Reducing recurrence of advanced melanoma with pembrolizumab
Prof Alex Eggermont - Paris-Sud University, Paris, France
Reducing recurrence of advanced melanoma with pembrolizumab ( Prof Alex Eggermont - Paris-Sud University, Paris, France )
25 Apr 2018
Results of KEYNOTE-054; melanoma patients treated with pembrolizumab.
Prof Alex Eggermont - Paris-Sud University, Paris, France
Results of KEYNOTE-054; melanoma patients treated with pembrolizumab. ( Prof Alex Eggermont - Paris-Sud University, Paris, France )
25 Apr 2018
Lenalidomide with rituximab for mantle cell lymphoma
Prof Jia Ruan - Weill Cornell Medicine and New York Presbyterian Hospital, New Y...
Lenalidomide with rituximab for mantle cell lymphoma ( Prof Jia Ruan - Weill Cornell Medicine and New York Presbyterian Hospital, New York, USA )
11 Dec 2017
A biological perspective for personalising immunotherapies
Dr Tom Lillie - Head of European Clinical Development, MSD, London, UK
A biological perspective for personalising immunotherapies ( Dr Tom Lillie - Head of European Clinical Development, MSD, London, UK )
6 Dec 2017
Editor's Choice for November 2017
Prof Gordon McVie - Founding Editor, ecancer
Editor's Choice for November 2017 ( Prof Gordon McVie - Founding Editor, ecancer )
4 Dec 2017
The promise of immunotherapy for elderly patients
Dr Alistair Greystoke - Newcastle University, Newcastle, UK
The promise of immunotherapy for elderly patients ( Dr Alistair Greystoke - Newcastle University, Newcastle, UK )
15 Nov 2017